Role of mitomycin-C in endoscopic dacryocystorhinostomy with lacrimal sac stenting
Keywords:ENDODCR. Mitomycin-C, Stenting
Background: This study critically evaluates the effectiveness of mitomycin-C in conventional endoscopic dacryocystorhinostomy (ENDODCR) that minimizes the reclosure of a neo-ostium by retaining an enlarged marsupialized lacrimal sac.
Methods: The combined retrospective and prospective study included 24 patients in the study group, who underwent endoscopic dacryocystorhinostomy in the Department of Otorhinolaryngology and Ophthalmology in a period of 1.5 years (June 2006 to January 2008).
Results: An 83.33% primary success rate was observed, without any serious complications. Obstruction of the neo-ostium with granulation tissue was observed in 20.83% cases. Overall, the success rate of group I was 91.67% as compared to 75% in group II.
Conclusions: Intra operative mitomycin-C application is effective in increasing the success rate of DCR surgery in standard nasolacrimal duct obstruction, and no significant complications resulted from its use.
Sharma BR. Non endoscopic endonasal dacryocystorhinostomy versus external dacryocystorhinostomy. Kathmandu Univ Med J. 2008;6(24):437-42.
Leong SC, Macewen CJ, White PS. A systematic review of outcomes after dacryocystorhinostomy in adults. Am J Rhinol Allerg. 2010;24(1):81-90.
Karkos PD, Leong SC, Sastry A, et al. Evidence-based applications of mitomycin-C in the nose. Am J Otolaryngol. 2011;32(5):422-5.
Agarwal S. Endoscopic dacryocystorhinostomy for acquired nasolacrimal duct obstruction. J Laryngol Otol. 2009;123(11):1226-8.
Fergie N, Jones NS. Dacryocystorhinostomy. In: Gleeson M, Browning GG, Burton MJ, Clarke R, John H, Jones NS, et al eds. Scott Brown’s otorhinolaryngology, head and neck surgery. 7th edn. London: Hodder Arnold; 2008;1689-1698.
Liao SL, Kao SC, Tseng JH, Chen MS, Hou PK. Results of intraoperative mitomycin C application in dacryocystorhinostomy. Br J Ophthalmol. 2000;84(8):903-6.
Zilelioğlu G, Uğurbaş SH, Anadolu Y, Akıner M, Aktürk T. Adjunctive use of mitomycin-C on endoscopic lacrimal surgery. Br J Ophthalmol. 1998;82(1):63-6.
McDonough M, Meiring JH. Endoscopic transnasal dacryocystorhinostomy. J Laryngeal Otol. 1989;103(6):585-7.
Jones LT. The cure of epiphora due to canalicular disorders, trauma and surgical failures on the lacrimal passages. Trans Am Acad Ophthalmol Otolaryngol. 1962;66:506-24.
Ishio K, Sugasawa M, Tayama N, Kaga K. Clinical usefulness of endoscopic intranasal dacryocystorhinostomy. Acta Otolaryngol Suppl. 2007;559:95-102.
Korkut AY, Teker AM, Ozsutcu M, Askiner O, Gedikli O. A comparison of endonasal with external dacryocystorhinostomy in revision cases. Eur Arch Otorhinolaryngol. 2011;268(3):377-81.
Araujo Filho BC, Voegels RL, Butugan O, Neto CD, Lessa MM. Endoscopic dacryocystorhinostomy. Brazil J Otorhinolaryngol. 2005;71:721-5.
Selig YK, Biesman BS, Rebeiz EE. Topical application of mitomycin-C in endoscopic dacryocystorhinostomy. Am J Rhino. 2000;14(3):205-7.
Apuhan T, Yildirim YS, Eroglu F. Effect of mitomycin-C on endoscopic dacryocystorhinostomy. J Craniofac Surg. 2011;22(6):2057-9.
Camara JG, Bengzon AU, Henson RD. The safety and efficacy of mitomycin-C in endonasal endoscopic laser assisted dacryocystorhinostomy. Ophthamic Plast Reconstr Surg. 2000;16(2):114-8.
Dolmetch AM, Gallon MA, Holds JB. Non laser endoscopic dacryocystorhinostomy with adjunctive mitomycin-C in children. Ophthalmol Plast Reconstruct Surg. 2008;24(5):390-3.
Yim M, Wormald PJ, Doucet M, Gill A, Kingdom T, Orlandi R, Crum A, Marx D, Alt J. Adjunctive techniques to dacryocystorhinostomy: an evidence‐based review with recommendations. InInternational Forum of Allergy & Rhinology 2020 Sep 2.
Ghosh S, Roychaudhury A, Roychaudhuri BK. Use of mitomycin-C in endo-DCR. Indian J Otolaryngol Head Neck Surg. 2006;58(4):368-9.
Prasannaraj T, Kumar P, Narasimhan I, Shivaprakash KV. Significance of adjunctive mitomycin-C in endoscopic dacryocystorhinostomy. Am J Otolaryngol. 2012;33(1):47-50.